Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Artificial Intelligence In Cancer Diagnostics Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market for artificial intelligence in cancer diagnostics has experienced remarkable expansion over the past few years. Projections indicate it will rise from $0.52 billion in 2025 to $0.69 billion in 2026, reflecting a compound annual growth rate (CAGR) of 31.3%. This historic growth was driven by factors such as the increasing volume of medical imaging data, the early integration of computer-aided diagnosis systems, a higher incidence of cancer cases, progress in imaging technologies, and the growing digital transformation of healthcare.
The market for artificial intelligence in cancer diagnostics is projected to experience substantial expansion in the coming years, reaching $2.02 billion by 2030 with a compound annual growth rate of 30.9%. This forecasted growth is fueled by factors such as the need for early cancer detection, the adoption of precision medicine, enhancements in AI-powered diagnostic accuracy, increased funding for oncology research, and the integration of genomic and imaging data. Key developments anticipated in this period encompass AI-supported medical image analysis, the advancement of early detection technologies, the incorporation of predictive oncology analytics, the automation of diagnostic processes, and the growing use of decision support systems.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12685&type=smp
Artificial Intelligence In Cancer Diagnostics Market Expansion Drivers: What Is Shaping Future Growth?
The increasing incidence of cancer is anticipated to drive the expansion of artificial intelligence within the cancer diagnostics market. Cancer involves the abnormal proliferation of cells, affecting various organs and resulting in substantial illness and death globally. In cancer diagnostics, artificial intelligence is employed to interpret medical imaging data with precision and speed, thereby supporting early identification and accurate classification of malignant growths. For example, according to data from the American Cancer Society, a US-based nonprofit, the United States is expected to see 2,041,910 new cancer cases and 618,120 deaths from the disease in 2025. Moreover, as reported in February 2024 by the World Health Organisation, an intergovernmental organization headquartered in Switzerland, around 20 million new cancer cases occurred in 2022, causing 9.7 million deaths, while roughly 53.5 million people were alive within five years after being diagnosed. As a result, the growing prevalence of cancer is projected to fuel the advancement of artificial intelligence in the cancer diagnostics market.
Artificial Intelligence In Cancer Diagnostics Market Segment Outlook: Which Categories Are Expanding The Fastest?
The artificial intelligence in cancer diagnostics market covered in this report is segmented –
1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization
Subsegments:
1) By Software Solutions: Imaging Analysis Software, Predictive Analytics Software, Decision Support Systems, Data Management Platforms
2) By Hardware: Imaging Devices, Biomarkers Detection Equipment, Computing Infrastructure
3) By Services: Consulting Services, Implementation Services, Maintenance And Support Services, Training Services
Artificial Intelligence In Cancer Diagnostics Market Strategic Trends: What Is Defining The Next Phase Of Growth?
In the artificial intelligence in cancer diagnostics market, major companies are prioritizing strategic partnerships to accelerate the rollout of AI-driven digital pathology technologies designed to assist in cancer detection. Such collaborations involve firms aligning their strengths and resources to pursue shared advantages and outcomes. A notable example occurred in October 2023, when F. Hoffmann-La Roche AG, a Swiss diagnostics and pharmaceutical firm, entered into a partnership with Ibex Medical Analytics, an Israeli medical technology company, alongside Amazon Web Services, Inc., a US-based provider of a widely adopted comprehensive cloud platform. This alliance enables pathology labs to leverage the navify Digital Pathology software platform, granting them access to Ibex’s AI-based decision support tools that help physicians identify breast and prostate cancer. The joint effort between Ibex Medical Analytics and Roche is creating cutting-edge AI-enhanced processes, aimed at helping pathologists and laboratories fully embrace the potential of digital transformation. These cloud-based digital pathology and AI offerings from Roche and Ibex are supported by Amazon Web Services (AWS), delivering a scalable and sustainable infrastructure for pathology labs.
Artificial Intelligence In Cancer Diagnostics Market Key Companies And Competitive Benchmarking
Major companies operating in the artificial intelligence in cancer diagnostics market are Microsoft Corporation; Siemens; Roche Holding AG; Google LCC; International Business Machines Corporation; Thermo Fisher Scientific Inc.; Illumina Inc.; Bio Rad Laboratories Inc.; Flatiron Health; Tempus Labs Inc.; Paige AI Inc.; OncoHealth Corporation; Path AI Inc.; Aidoc; Sophia Genetics SA; Digital Diagnostics Inc.; Prognos Health; Aidence; Kheiron Medical Technologies Limited; Zebra Medical Vision; Niramai; Enlitic Inc.; Therapixel; Medial EarlySign Ltd.; Freenome; SkinVision B.V.
Access The Complete Artificial Intelligence In Cancer Diagnostics Market Report:
Artificial Intelligence In Cancer Diagnostics Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Artificial Intelligence In Cancer Diagnostics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=12685&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.